Skip to content
p1000007

Seminar Title

 

Seminar PH2 – Cancer Therapy: review of the present and a look to the future

Affiliation

Uppsala University Hospital

Country

Sweden

1. Current Status, Position

Dr. Gullbo (MD PhD) is Senior Consultant in oncology, with an emphasis on breast cancer. He is also an associate professor in academic research focused on research and development of new anticancer drugs.

2. Education

  • 1996: MSc in Pharmacy, Faculty of Pharmacy, Uppsala University.
  • 2002: Medical Degree, Faculty of Medicine, Uppsala University.
  • 2003: PhD in Clinical Pharmacology, Institution of Medical Sciences, Uppsala University (Thesis: Preclinical Development of New Alkylating Oligopeptides for Cancer Therapy).
  • 2009: Associate Professor in experimental Clinical Pharmacology.
  • 2012: Consultant/Specialist in Clinical Pharmacology, 2011 – Consultant/Specialist in Oncology.

3. Research Area

Dr Gullbo´s research is focused on preclinical development and evaluation of new cancer therapies. His research has been based on rational synthesis, traditional screens of chemical libraries as well as investigations of natural products. Three compounds are currently being investigated in clinical trials. As a clinician, Dr Gullbo has participated in numerous clinical trials and has special interest in breast cancer treatment.

4. Conflict of interest: none

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.